OHB's Orbit Milestone Fails to Break the Grip of Its Dilution Hangover

OHB shares jump after Isar's orbital success, yet stock remains 19% below 50-day average amid capital raise dilution and weak retail uptake.

The celebration was real, but so was the skepticism. When Isar Aerospace's "Onward and Upward" mission reached orbit from Norway's Andøya spaceport on Monday — succeeding where a March 2025 attempt had failed — OHB shares responded with a 4.7 percent pop to EUR 194.80. Yet for a company whose stock has been battered by a poorly received capital raise, one good day hardly rewrites the tape.

The rally followed a Friday close of EUR 186.00, a level that itself reflected a brutal stretch. Over the past month, OHB has shed roughly 21 percent of its value, and even Monday's advance leaves the equity trading about 19 percent below its 50-day moving average of EUR 239.51. The stock sits miles from its 52-week high of EUR 688.00, reached back in May.

A Structural Argument Takes Shape

Berenberg responded to the successful launch by issuing a buy recommendation on OHB with a price target of EUR 358 — more than 80 percent above current levels. The bank also reiterated a buy on Rocket Lab while keeping Avio at "hold."

The analysts' logic rests on a striking statistic: in 2025, just 11 of 164 European payloads flew aboard Ariane 6 or Vega C rockets — a mere 7 percent. Since the start of 2026, that figure has deteriorated further, with only one of 119 European payloads using the established continental launchers. Meanwhile, 94 percent of launches in the same period have gone to SpaceX's Falcon 9.

That dependency is precisely what Europe now wants to unwind. The European Space Agency's so-called Launcher Challenge carries commitments of EUR 902 million, of which EUR 543.6 million are already under contract. Berenberg estimates that roughly 70 percent of annual European payload mass above one tonne could eventually shift to alternative providers such as Isar Aerospace. Germany, Norway, Sweden and Britain are all pushing for independent launch capacity — Chancellor Merz visited the Norwegian site as far back as March.

For OHB, positioned as an established system integrator, the thesis is straightforward: a diversified European launch market would create new opportunities for suppliers across the value chain. Monday's orbital success, in that reading, is less a single-company story than a potential inflection point for an entire industrial ecosystem.

The Weight of Fresh Equity

But the market's recent behavior suggests investors are focused on a more immediate concern: dilution. Just over two months ago, OHB closed a capital increase that raised roughly EUR 484 million gross. The first tranche contributed EUR 481.6 million, with a further EUR 2.3 million from a second tranche.

Retail participation was strikingly thin. Of the 97,092 shares offered to small shareholders, only 7,635 were subscribed. Rights for 89,457 new shares expired worthless — a telling vote of no-confidence from the very investors the company might have hoped to bring along.

Institutional investors stepped up, but the market's verdict has been unforgiving. The share price has fallen roughly 28 percent since OHB joined the SDAX in August, replacing Klöckner & Co. A potential promotion to the TecDAX at the next regular index review in September would raise the stock's visibility, though it is unlikely to resolve the underlying tension between a swelling order book and an expanded share count.

A Billion-Euro Win That Barely Moved the Needle

The disconnect between operational news and price action has been stark. Just over a week ago, Handelsblatt reported that satellite operator SES had awarded OHB a contract worth nearly EUR 1 billion to develop and build 18 satellite platforms for the IRIS² European communications system. The first satellites are slated for launch in 2029, with data transmission beginning in 2030.

The stock's response: a modest 1.6 percent gain. No euphoria, no sustained breakout — just the quiet arithmetic of a market weighing future earnings against a larger share base. The order book may well fuel significant profit growth from 2027 onward, but those anticipated earnings must now be spread across more shares.

The chart tells the same story of resistance. The 50-day average has acted as a ceiling rather than a floor, and Monday's jump — however welcome — has yet to pierce the medium-term downtrend that took hold after the capital increase. For now, OHB presents investors with a genuine puzzle: an operating story that keeps strengthening, and a share price that keeps finding reasons to hesitate.